Solid Biosciences to Participate at Upcoming Investor Conferences
05 9월 2023 - 9:56PM
Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company
developing genetic medicines for neuromuscular and cardiac
diseases, today announced that Bo Cumbo, President and Chief
Executive Officer, will participate in the following two upcoming
investor conferences:
- Baird Global Healthcare
Conference – New York, NYTuesday, September 12,
2023, at 10:15 AM ET.
- H.C. Wainwright & Co.
Healthcare Conference – New York, NYWednesday,
September 13, 2023, at 3:30 PM ET.
A live webcast of the H.C Wainwright & Co. presentation will
be available on the Events page of the Investors section of the
Company website or by clicking here. A webcast replay will be
archived for 30 days on the Events page. The Baird presentation is
only available to clients of Baird.
Institutional investors interested in meeting with management
during the conference may reach out to their Baird or H.C.
Wainwright & Co. representatives.
About Solid Biosciences
Solid Biosciences is a life science company
focused on advancing a portfolio of neuromuscular and cardiac
programs, including SGT-003, a differentiated gene transfer
candidate for the treatment of Duchenne muscular dystrophy
(Duchenne), AVB-401 a gene therapy program for the treatment of
BAG3 mediated dilated cardiomyopathy, AVB-202-TT, a gene therapy
program for the treatment of Friedreich’s Ataxia, and additional
assets for the treatment of fatal cardiac diseases. Solid aims to
be the center of excellence across a given disease spectrum
bringing together those with expertise in science, technology,
disease management, and care. Patient-focused and founded by those
directly impacted, Solid’s mandate is to improve the daily lives of
patients living with these devastating diseases. For more
information, please visit www.solidbio.com.Solid
Biosciences Investor Contact:Leah MonteiroVP, Investor
Relations &
Communications617-821-4427lmonteiro@solidbio.com
Solid Biosciences (NASDAQ:SLDB)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Solid Biosciences (NASDAQ:SLDB)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024